We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+4.76%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$13.4B
AUM Growth
+$1.43B
(+12%)
Cap. Flow
+$857M
Cap. Flow
% of AUM
6.4%
Top 10 Holdings %
Top 10 Hldgs %
14.37%
Holding
602
New
156
Increased
172
Reduced
106
Closed
146
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$175M |
| 2 |
Lowe's Companies
LOW
|
+$167M |
| 3 |
AutoZone
AZO
|
+$127M |
| 4 |
Northern Trust
NTRS
|
+$127M |
| 5 |
Merck
MRK
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$133M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$126M |
| 3 |
KeyCorp
KEY
|
+$113M |
| 4 |
Walmart Inc
WMT
|
+$110M |
| 5 |
OA
Orbital ATK, Inc.
OA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.72% |
| 2 | Industrials | 14.06% |
| 3 | Consumer Discretionary | 12.07% |
| 4 | Healthcare | 11.22% |
| 5 | Financials | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Aclaris Therapeutics
ACRS
$851M
| $12.1M | 0.09% |
467,884
+215,201
| +85% | +$5.77M |
|
|
FMSA
227
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $11.9M | 0.09% |
2,492,326
-3,671,083
| -60% | -$11.9M |
|
|
OPLN
228
Openlane
OPLN
$4.62B
| $11.8M | 0.09% |
+655,821
| New | +$10.8M |
|
229
United Parcel Service
UPS
$87.7B
| $11.8M | 0.09% |
+98,547
| New | +$11.2M |
|
|
MSCC
230
DELISTED
Microsemi Corp
MSCC
| $11.7M | 0.09% |
226,882
+148,289
| +189% | +$7.45M |
|
231
JPMorgan Chase
JPM
$947B
| $11.4M | 0.08% |
118,871
+58,372
| +96% | +$5.38M |
|
|
LVLT
232
DELISTED
Level 3 Communications Inc
LVLT
| $11.2M | 0.08% |
210,000
-778,573
| -79% | -$43.4M |
|
|
DOC
233
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $11.1M | 0.08% |
625,000
+375,000
| +150% | +$6.92M |
|
234
Chord Energy
CHRD
$7.46B
| $10.9M | 0.08% |
+1,199,040
| New | +$9.39M |
|
|
CAVM
235
DELISTED
Cavium, Inc.
CAVM
| $10.9M | 0.08% |
+164,890
| New | +$10.4M |
|
236
Wheaton Precious Metals
WPM
$56.9B
| $10.8M | 0.08% |
563,781
+191,146
| +51% | +$3.76M |
|
|
DCH
237
Dauch Corp
DCH
$1.35B
| $10.3M | 0.08% |
+583,277
| New | +$8.96M |
|
238
United Airlines
UAL
$41.9B
| $10.1M | 0.08% |
165,508
-31,792
| -16% | -$2.12M |
|
239
Cisco
CSCO
$476B
| $10.1M | 0.08% |
299,491
-700,138
| -70% | -$22.3M |
|
|
ASAP
240
CALL
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
| $10M | 0.07% |
50,000
| – | – |
|
|
ASAP
241
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
| $10M | 0.07% |
50,000
| – | – |
|
242
Carlyle Secured Lending
CGBD
$741M
| $9.78M | 0.07% |
519,375
+9,275
| +2% | +$171K |
|
243
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $9.76M | 0.07% |
110,000
+20,000
| +22% | +$1.76M |
|
|
GNMK
244
DELISTED
GenMark Diagnostics, Inc
GNMK
| $9.76M | 0.07% |
1,013,881
+349,819
| +53% | +$3.63M |
|
245
Simply Good Foods
SMPL
$988M
| $9.66M | 0.07% |
+825,000
| New | +$9.77M |
|
|
DERM
246
DELISTED
Dermira, Inc.
DERM
| $9.48M | 0.07% |
351,059
+6,270
| +2% | +$164K |
|
|
IPXL
247
DELISTED
Impax Laboratories, Inc.
IPXL
| $9.47M | 0.07% |
+466,515
| New | +$8.92M |
|
|
BLVD
248
CALL
DELISTED
Boulevard Acquisition Corp. II Class A Common Stock
BLVD
| $9.45M | 0.07% |
945,134
| – | – |
|
249
CALL
Theriva Biologics
TOVX
$10.3M
| $9.33M | 0.07% |
1,143
| – | – |
|
|
AERI
250
DELISTED
Aerie Pharmaceuticals
AERI
| $9.3M | 0.07% |
191,282
+131,282
| +219% | +$7.16M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q3 2017 Portfolio in Review
As of Q3 2017, Alyeska Investment Group held 602 positions worth $13.4B, up 12% from $12B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Alyeska Investment Group deployed $857M of net new capital in Q3 2017, opening 156 new positions and adding to 172 existing holdings. Its largest new stake was AutoZone: 238,293 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was AbbVie, an estimated $133M trimmed.
- Alyeska Investment Group's largest Q3 2017 buy was AutoZone: 238,293 shares worth $142M.
- Alyeska Investment Group added most to Texas Instruments in Q3 2017, an estimated $175M increase.
- Alyeska Investment Group's biggest Q3 2017 reduction was AbbVie, cutting an estimated $133M.
- Alyeska Investment Group fully exited Reynolds American Inc in Q3 2017, selling an estimated $126M.
- Alyeska Investment Group's ten largest holdings make up 14% of its $13.4B portfolio in Q3 2017.
- Alyeska Investment Group opened 156 new positions and closed 146 in Q3 2017.
- Alyeska Investment Group's portfolio value rose 12% quarter-over-quarter to $13.4B.
Based on Alyeska Investment Group's 13F filing for Q3 2017, filed 14 Nov 2017.